Impact of the Covid-19 lockdown on cannabis users in France. Results of the 2020 Cannabis Online survey
Memo, OFDT, 22 p.
December 2020
The introduction of lockdown measures by the public authorities between 17 March and 11 May 2020 in response to the Covid-19 pandemic in France yielded dramatic changes in consumption practices of cannabis users. The OFDT set up, in the period following lockdown, a quantitative online survey of cannabis users recruited via the social network Facebook. The aim of this survey is to gain a better understanding of the patterns of cannabis use in France and the impact of lockdown on practices.
The results underline that a majority of cannabis users continued to use in the exceptional circumstances of lockdown, even though a large proportion of them changed their use behaviour. The survey shows an increase in the use of cannabis during lockdown, particularly among the most regular users, which is reflected both in an increase in the number of joints smoked on one occasion and in more frequent morning and earlier daytime use. Contrary to fear of a generalised shortage, the accessibility of cannabis remained significant in this period.
Furthermore, while some respondents reported increased consumption of alcohol or tobacco during lockdown, the transfer to other products was infrequent due to the adaptation of the cannabis market to the new constraints imposed by the situation.
Authors : Alex Brissot, Antoine Philippon, Stanislas Spilka
Download the PDF file (1,16 Mo)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
